Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoparathyroidism | 35 | 2024 | 136 | 11.880 |
Why?
|
Parathyroid Hormone | 34 | 2024 | 1803 | 3.830 |
Why?
|
Hypocalcemia | 11 | 2025 | 205 | 2.450 |
Why?
|
Parathyroid Glands | 7 | 2024 | 522 | 1.790 |
Why?
|
Calcium | 28 | 2024 | 5792 | 1.450 |
Why?
|
Hormone Replacement Therapy | 8 | 2021 | 757 | 1.230 |
Why?
|
Hyperparathyroidism, Primary | 6 | 2022 | 164 | 1.180 |
Why?
|
Receptors, Calcium-Sensing | 3 | 2025 | 320 | 1.020 |
Why?
|
Hypercalcemia | 5 | 2025 | 424 | 1.010 |
Why?
|
Diphtheria Toxin | 2 | 2017 | 253 | 1.000 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 7 | 2024 | 305 | 0.970 |
Why?
|
Hypercalciuria | 2 | 2017 | 31 | 0.970 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2017 | 103 | 0.940 |
Why?
|
Nephrocalcinosis | 1 | 2022 | 51 | 0.810 |
Why?
|
Phosphates | 7 | 2023 | 765 | 0.780 |
Why?
|
Hyperphosphatemia | 2 | 2017 | 38 | 0.670 |
Why?
|
Vitamin D | 15 | 2023 | 3311 | 0.660 |
Why?
|
Fibrous Dysplasia, Polyostotic | 3 | 2024 | 39 | 0.660 |
Why?
|
Parathyroidectomy | 4 | 2017 | 244 | 0.650 |
Why?
|
Calcitriol | 6 | 2024 | 303 | 0.650 |
Why?
|
Recombinant Proteins | 8 | 2021 | 6512 | 0.600 |
Why?
|
Databases, Genetic | 1 | 2025 | 1758 | 0.580 |
Why?
|
Periodicals as Topic | 2 | 2018 | 1470 | 0.540 |
Why?
|
Naphthalenes | 1 | 2017 | 198 | 0.520 |
Why?
|
Databases as Topic | 1 | 2018 | 475 | 0.520 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 391 | 0.500 |
Why?
|
Receptors, Parathyroid Hormone | 5 | 1999 | 332 | 0.480 |
Why?
|
Hypophosphatemia, Familial | 2 | 2012 | 32 | 0.450 |
Why?
|
Osteogenesis Imperfecta | 1 | 2014 | 81 | 0.440 |
Why?
|
Hajdu-Cheney Syndrome | 1 | 2013 | 2 | 0.430 |
Why?
|
Editorial Policies | 1 | 2018 | 460 | 0.420 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.410 |
Why?
|
Osteoporosis | 4 | 2022 | 1606 | 0.410 |
Why?
|
Receptor, Notch2 | 1 | 2013 | 90 | 0.410 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 35 | 0.400 |
Why?
|
Rickets | 1 | 2012 | 70 | 0.390 |
Why?
|
Fractures, Bone | 3 | 2023 | 2063 | 0.380 |
Why?
|
Calcium, Dietary | 4 | 2022 | 533 | 0.370 |
Why?
|
Fibroblast Growth Factors | 6 | 2023 | 873 | 0.370 |
Why?
|
Collagen Type I | 1 | 2014 | 620 | 0.360 |
Why?
|
Osteomalacia | 3 | 2008 | 60 | 0.360 |
Why?
|
Genes, Dominant | 3 | 2013 | 856 | 0.360 |
Why?
|
Bone and Bones | 7 | 2023 | 2590 | 0.340 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 244 | 0.330 |
Why?
|
Information Dissemination | 1 | 2018 | 1141 | 0.330 |
Why?
|
Gene Deletion | 2 | 2014 | 2674 | 0.320 |
Why?
|
Germ-Line Mutation | 2 | 2013 | 1887 | 0.290 |
Why?
|
Parathyroid Hormone-Related Protein | 3 | 2015 | 327 | 0.290 |
Why?
|
Nuclear Proteins | 3 | 2012 | 5804 | 0.280 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2022 | 1248 | 0.280 |
Why?
|
Mutation | 7 | 2025 | 30266 | 0.270 |
Why?
|
Pedigree | 7 | 2014 | 4545 | 0.260 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 57 | 0.260 |
Why?
|
Humans | 71 | 2025 | 768970 | 0.230 |
Why?
|
Fascioliasis | 2 | 2000 | 14 | 0.230 |
Why?
|
Fasciola hepatica | 2 | 2000 | 15 | 0.230 |
Why?
|
Transcription Factors | 4 | 2014 | 12174 | 0.230 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2024 | 53 | 0.220 |
Why?
|
Bone Density Conservation Agents | 2 | 2023 | 797 | 0.220 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18354 | 0.210 |
Why?
|
Amiloride | 1 | 2022 | 116 | 0.210 |
Why?
|
Ovulation Induction | 1 | 2024 | 277 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2297 | 0.200 |
Why?
|
Homeostasis | 5 | 2023 | 3347 | 0.200 |
Why?
|
Hyperparathyroidism | 3 | 2018 | 339 | 0.190 |
Why?
|
Urolithiasis | 1 | 2022 | 125 | 0.180 |
Why?
|
Endocrine System Diseases | 1 | 2023 | 250 | 0.180 |
Why?
|
Adenoma | 1 | 2011 | 2163 | 0.180 |
Why?
|
Female | 36 | 2024 | 397515 | 0.170 |
Why?
|
Anthelmintics | 1 | 2000 | 83 | 0.170 |
Why?
|
Homozygote | 2 | 2015 | 1780 | 0.170 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2024 | 504 | 0.170 |
Why?
|
Minerals | 1 | 2021 | 282 | 0.160 |
Why?
|
Male | 33 | 2024 | 365203 | 0.160 |
Why?
|
Adult | 20 | 2024 | 223851 | 0.160 |
Why?
|
Mice, Transgenic | 3 | 2017 | 9565 | 0.150 |
Why?
|
Chromogranins | 1 | 2019 | 160 | 0.150 |
Why?
|
Thyroidectomy | 3 | 2023 | 914 | 0.150 |
Why?
|
Animals | 25 | 2024 | 169335 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2019 | 4124 | 0.140 |
Why?
|
Puberty, Precocious | 1 | 2019 | 166 | 0.140 |
Why?
|
Cholestasis | 1 | 2000 | 385 | 0.140 |
Why?
|
Osteoporotic Fractures | 1 | 2022 | 417 | 0.140 |
Why?
|
Brain | 1 | 2024 | 27453 | 0.140 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 194 | 0.140 |
Why?
|
Luminescent Agents | 1 | 2017 | 29 | 0.140 |
Why?
|
Neuralgia | 1 | 2024 | 622 | 0.140 |
Why?
|
Poisons | 1 | 2017 | 37 | 0.140 |
Why?
|
Middle Aged | 20 | 2024 | 223737 | 0.140 |
Why?
|
Glucuronidase | 1 | 2018 | 205 | 0.130 |
Why?
|
Kidney | 9 | 2023 | 7058 | 0.130 |
Why?
|
Hyponatremia | 1 | 2019 | 279 | 0.130 |
Why?
|
Depsipeptides | 1 | 2016 | 96 | 0.130 |
Why?
|
Mutation, Missense | 2 | 2015 | 2592 | 0.120 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 422 | 0.120 |
Why?
|
Bone Density | 3 | 2024 | 3574 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2000 | 864 | 0.120 |
Why?
|
Mesenchymoma | 2 | 2008 | 50 | 0.120 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2014 | 20 | 0.120 |
Why?
|
Authorship | 1 | 2018 | 289 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2024 | 65480 | 0.120 |
Why?
|
Peer Review, Research | 1 | 2018 | 344 | 0.120 |
Why?
|
Genetic Variation | 2 | 2025 | 6611 | 0.120 |
Why?
|
Bradykinin | 1 | 1995 | 205 | 0.120 |
Why?
|
Acrylic Resins | 1 | 1995 | 135 | 0.120 |
Why?
|
Calcium Citrate | 1 | 2013 | 8 | 0.110 |
Why?
|
Uremia | 4 | 1996 | 202 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13510 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2012 | 17629 | 0.110 |
Why?
|
Mice | 9 | 2023 | 82072 | 0.110 |
Why?
|
Pseudohypoparathyroidism | 3 | 2019 | 87 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2008 | 1789 | 0.110 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13427 | 0.110 |
Why?
|
Spasm | 1 | 2013 | 131 | 0.110 |
Why?
|
Double-Blind Method | 3 | 2018 | 12467 | 0.100 |
Why?
|
Lanthanum | 1 | 2012 | 30 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.100 |
Why?
|
Finger Phalanges | 1 | 2013 | 41 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 606 | 0.100 |
Why?
|
HEK293 Cells | 3 | 2017 | 4290 | 0.100 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.100 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2981 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 969 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 687 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4785 | 0.100 |
Why?
|
Polyamines | 1 | 2012 | 133 | 0.100 |
Why?
|
Aged | 10 | 2024 | 171786 | 0.090 |
Why?
|
Reference Values | 1 | 2018 | 4940 | 0.090 |
Why?
|
Acetates | 1 | 2012 | 317 | 0.090 |
Why?
|
Chelating Agents | 1 | 2012 | 385 | 0.090 |
Why?
|
Heterozygote | 2 | 2019 | 2798 | 0.090 |
Why?
|
Family Health | 2 | 2012 | 1255 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3441 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3836 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 385 | 0.090 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2067 | 0.090 |
Why?
|
Tissue Extracts | 2 | 2008 | 139 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 2 | 2004 | 124 | 0.080 |
Why?
|
Genes, Recessive | 1 | 2012 | 625 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2414 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4413 | 0.080 |
Why?
|
Genetic Linkage | 2 | 2013 | 2342 | 0.080 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2008 | 36 | 0.080 |
Why?
|
Diphosphonates | 2 | 2023 | 634 | 0.080 |
Why?
|
Xenopus laevis | 1 | 2012 | 966 | 0.080 |
Why?
|
Angiodysplasia | 1 | 2008 | 22 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2018 | 3443 | 0.080 |
Why?
|
Hemangiopericytoma | 1 | 2008 | 71 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 1514 | 0.070 |
Why?
|
Jaw Neoplasms | 1 | 2008 | 71 | 0.070 |
Why?
|
Cell Lineage | 1 | 2017 | 2576 | 0.070 |
Why?
|
Oocytes | 1 | 2012 | 1172 | 0.070 |
Why?
|
Creatinine | 2 | 2023 | 1917 | 0.070 |
Why?
|
Thigh | 1 | 2008 | 239 | 0.070 |
Why?
|
Adolescent | 6 | 2024 | 89244 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2019 | 1742 | 0.070 |
Why?
|
Leg Ulcer | 1 | 2007 | 71 | 0.070 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2493 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2360 | 0.070 |
Why?
|
Chickens | 1 | 2008 | 845 | 0.070 |
Why?
|
Models, Molecular | 2 | 2013 | 5404 | 0.070 |
Why?
|
Nose Neoplasms | 1 | 2008 | 250 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1672 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3726 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1264 | 0.060 |
Why?
|
Registries | 1 | 2021 | 8384 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2014 | 13021 | 0.060 |
Why?
|
Calciphylaxis | 1 | 2007 | 129 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2022 | 7885 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4919 | 0.060 |
Why?
|
COS Cells | 2 | 2015 | 1135 | 0.060 |
Why?
|
Calcium Channel Agonists | 1 | 2004 | 26 | 0.060 |
Why?
|
Sodium Fluoride | 1 | 2024 | 67 | 0.060 |
Why?
|
Foot | 1 | 2008 | 577 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2100 | 0.060 |
Why?
|
DNA | 2 | 2014 | 7214 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4607 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6320 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20776 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12801 | 0.050 |
Why?
|
Base Sequence | 4 | 2012 | 12430 | 0.050 |
Why?
|
Facial Bones | 1 | 2024 | 209 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2007 | 383 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2007 | 408 | 0.050 |
Why?
|
Mice, Knockout | 1 | 1997 | 14484 | 0.050 |
Why?
|
Young Adult | 3 | 2013 | 60131 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6991 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2018 | 59739 | 0.050 |
Why?
|
Alendronate | 1 | 2022 | 174 | 0.050 |
Why?
|
Neoplasms | 2 | 2008 | 22389 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15889 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2023 | 239 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4251 | 0.040 |
Why?
|
Renin | 1 | 2022 | 648 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2022 | 361 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
Acetaminophen | 1 | 2023 | 556 | 0.040 |
Why?
|
Sweden | 1 | 2022 | 1382 | 0.040 |
Why?
|
NAD | 1 | 2023 | 618 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 838 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2022 | 652 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22379 | 0.040 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1998 | 127 | 0.040 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 85 | 0.040 |
Why?
|
CHO Cells | 2 | 2016 | 1379 | 0.040 |
Why?
|
Comorbidity | 1 | 2012 | 10592 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 881 | 0.040 |
Why?
|
Republic of Korea | 1 | 2019 | 592 | 0.040 |
Why?
|
Imidazoles | 1 | 2023 | 1169 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1136 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2016 | 3775 | 0.040 |
Why?
|
Hypophosphatemia | 1 | 2018 | 93 | 0.040 |
Why?
|
Family | 1 | 2008 | 3208 | 0.040 |
Why?
|
Down-Regulation | 2 | 1995 | 2942 | 0.040 |
Why?
|
Cricetinae | 2 | 2016 | 2423 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2018 | 12806 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36854 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1998 | 326 | 0.030 |
Why?
|
Peptide Fragments | 2 | 1999 | 5151 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2023 | 1171 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54962 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1758 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2021 | 1445 | 0.030 |
Why?
|
Estrogens | 1 | 2022 | 1536 | 0.030 |
Why?
|
Binding Sites | 2 | 2016 | 6023 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2018 | 874 | 0.030 |
Why?
|
Cohort Studies | 2 | 2022 | 41808 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 148 | 0.030 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 692 | 0.030 |
Why?
|
RANK Ligand | 1 | 2017 | 321 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1998 | 1683 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9384 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1154 | 0.030 |
Why?
|
Cellulose | 1 | 1995 | 117 | 0.030 |
Why?
|
Cricetulus | 1 | 2016 | 812 | 0.030 |
Why?
|
Integrases | 1 | 2017 | 520 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2734 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 621 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 371 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2932 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 6011 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 776 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2024 | 2426 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 1995 | 367 | 0.030 |
Why?
|
Child | 3 | 2024 | 80960 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1833 | 0.030 |
Why?
|
Calcium Compounds | 1 | 2012 | 40 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2008 | 19023 | 0.030 |
Why?
|
Skull | 1 | 2017 | 830 | 0.020 |
Why?
|
Mutagenesis | 1 | 2016 | 1229 | 0.020 |
Why?
|
United States | 2 | 2017 | 73186 | 0.020 |
Why?
|
Sulfones | 1 | 1995 | 448 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2569 | 0.020 |
Why?
|
Genetic Engineering | 1 | 1997 | 936 | 0.020 |
Why?
|
Kidney Calculi | 1 | 2016 | 469 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1153 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1997 | 4168 | 0.020 |
Why?
|
Ligands | 1 | 1998 | 3283 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3431 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39394 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3057 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3956 | 0.020 |
Why?
|
Siblings | 1 | 2014 | 828 | 0.020 |
Why?
|
Signal Transduction | 3 | 2017 | 23653 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2016 | 812 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16731 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1199 | 0.020 |
Why?
|
Cataract | 1 | 2016 | 837 | 0.020 |
Why?
|
Ultrasonography | 2 | 2019 | 6002 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42683 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21547 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2022 | 81903 | 0.020 |
Why?
|
Rats | 4 | 1998 | 23786 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2012 | 901 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2012 | 2749 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6901 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6673 | 0.020 |
Why?
|
Polymers | 1 | 1995 | 1632 | 0.020 |
Why?
|
Anaphylaxis | 1 | 1995 | 758 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3449 | 0.020 |
Why?
|
Rats, Wistar | 3 | 1996 | 1890 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5928 | 0.020 |
Why?
|
Pressure Ulcer | 1 | 2007 | 159 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10400 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4265 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2022 | 7460 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2537 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2017 | 3335 | 0.010 |
Why?
|
Health Status | 1 | 2018 | 4095 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5033 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7578 | 0.010 |
Why?
|
Citrates | 1 | 2004 | 134 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9621 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14201 | 0.010 |
Why?
|
Cell Line | 2 | 2012 | 15604 | 0.010 |
Why?
|
Molecular Probes | 2 | 1995 | 309 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10847 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 30265 | 0.010 |
Why?
|
Leg | 1 | 2007 | 1089 | 0.010 |
Why?
|
Opossums | 1 | 2001 | 104 | 0.010 |
Why?
|
Cholangiography | 1 | 2000 | 182 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9344 | 0.010 |
Why?
|
Paraneoplastic Syndromes | 1 | 2001 | 154 | 0.010 |
Why?
|
Bile Ducts | 1 | 2000 | 288 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2173 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8748 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15879 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11932 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 22296 | 0.010 |
Why?
|
Ischemia | 1 | 2007 | 1900 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 600 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 1536 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2001 | 1469 | 0.010 |
Why?
|
Odds Ratio | 1 | 2008 | 9684 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2007 | 1300 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12095 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1441 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 947 | 0.010 |
Why?
|
Urine | 1 | 1995 | 362 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12562 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1995 | 1305 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5763 | 0.010 |
Why?
|
Blood | 1 | 1995 | 599 | 0.010 |
Why?
|
Haplotypes | 1 | 1998 | 2725 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4625 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7609 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12253 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 74976 | 0.000 |
Why?
|